Catalyst Wire Dossier Catalyst Wire Dossier

Meningococcal B vaccine candidate 2

· Novartis Vaccines
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Meningococcal B vaccine candidate 2, covering 2016-12-01 to 2016-12-01. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Safety and Immune Response of Two Serogroup B Meningococcal Vaccines Administered to Healthy Adolescents [Phase 2]

See pricing